Abeona Therapeutics Inc

XNAS:ABEO 4:00:00 PM EDT

5.41

+0.05 (+0.93%)

: $5.35 -0.06 (-1.11%)

Market Cap (Intraday)	277.41M
Current PE	4.85
Forward PE	4.75
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$5.19 Million
Adjusted EPS	-$0.28

See more estimates

10-Day MA	$5.44
50-Day MA	$6.19
200-Day MA	$5.81

See more pivots

Abeona Therapeutics Inc Stock, XNAS:ABEO

6555 Carnegie Avenue, 4th floor, Cleveland, Ohio 44103

United States of America

Phone: +1.646.813.4701

Number of Employees: 84

http://www.abeonatherapeutics.com

Description

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.